The Future of Enrollment
Needed New Infrastructure
SplashBIO was created to modernize trial enrollment for the biomarker era.
Clinical Trial Enrollment Is Changing
Biomarkers, digital assessments, and real-world data are transforming how participants are identified for clinical trials.
But traditional enrollment workflows were built for a different era.
Closing that gap is the reason SplashBIO exists.
Built From Deep Enrollment Experience
After more than 15 years building clinical trial enrollment operations through Splash Clinical, it became increasingly clear that biomarker-driven research would require a fundamentally different approach to trial enrollment and pre-screening.
That conviction became SplashBIO: an independent platform company focused on biomarker-driven enrollment infrastructure for modern clinical trials.
Independent by Design
Independence is deliberate. The platform is designed to support sponsors, sites, enrollment organizations, advocacy groups, and research partners across the broader clinical research ecosystem.
The future of enrollment requires collaboration across modern research networks.
Built for What Comes Next
SplashBIO is initially focused on Alzheimer’s disease and neurology research, where biomarker-driven enrollment infrastructure may dramatically improve trial efficiency.
But the opportunity is much larger.
As biomarkers continue transforming clinical research, the need for modern enrollment infrastructure will continue to grow across therapeutic areas.
Better Trial Enrollment
Starts Earlier.
Let’s modernize clinical trial enrollment together and unlock a new era of efficiency.